Cited by 869Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus researchViral Infections and Immunology Research

The DOI matches its Crossref record; 251 of the 253 references it cites were found in a registry or an index.

Recommendations for the Management of Herpes Zoster

Dworkin, Robert H., Johnson, Robert W., Breuer, Judith, Gnann, John W., Levin, Myron J., Backonja, Miroslav, Betts, Robert F., Gershon, Anne A., Haanpää, Maija L., McKendrick, Michael W., Nurmikko, Turo J., Oaklander, Anne Louise, Oxman, Michael N., Langston, Deborah Pavan, Petersen, Karin L., Rowbotham, Michael C., Schmader, Kenneth E., Stacey, Brett R., Tyring, Stephen K., Wijck, Albert J. M. van, Wallace, Mark S., Wassilew, Sawko W., Whitley, Richard J.·2007·Clinical Infectious Diseases

DOI 10.1086/510206

Open this paper in CoChat — free account

Abstract

The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1086/510206

Cites

251 of 251 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care
Fried, L. P., Ferrucci, L., Darer, J., Williamson, J. D., & Anderson, G. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m255 · Cited by 4,032
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Self-citation
Gabapentin for the Treatment of Postherpetic Neuralgia A Randomized Controlled Trial
Rowbotham, M. C. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,418
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,389
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,337
Advances in Neuropathic Pain
Dworkin, R. H., Bačkonja, M., Rowbotham, M. C., Allen, R. R., Argoff, C., Bennett, G. J., Bushnell, M. C., Farrar, J. T., Galer, B. S., Haythornthwaite, J. A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.11.1524 · Cited by 1,213
Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management
Woolf, C. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00010 · Cited by 1,134
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Weaver, D. F., & Houlden, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042580 · Cited by 1,080
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 960
Best evidence synthesis: An intelligent alternative to meta-analysis
Slavin, R. E. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00097-a · Cited by 951

Show all 253 references

Research works printed but not linked: 10

Rowbotham, 2001, Spectrum of pain mechanisms contributing to PHN, 183
Johnson, 2002, Improving the management of varicella, herpes zoster and zoster-associated pain. Recommendations from the IHMF Management Strategies Workshop
Dworkin, 2005, Strategies for the prevention of neuropathic pain, 39
Brentjens, Reduction of postherpetic neuralgia in herpes zoster: a study of the effects of gabapentin with valacyclovir during acute zoster outbreaks
Rowbotham, 2004, Pregabalin significantly reduces neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia by day 3 of treatment, 48
Brentjens, A double-blind randomized study of the use of 2 grams vs. 1 gram valacyclovir TID for 7 days in the treatment of acute herpes zoster in immunocompromised individuals
Sullivan, Famciclovir in the management of acute herpes zoster in HIV+ patients
Ragozzino, 1982, Population-based study of herpes zoster and its sequelae, Medicine, 61, 310, 10.1097/00005792-198209000-00003 · DOI
Oxman, Efficacy of zoster vaccine according to dermatome region
Pavan-Langston, 2005, Viral disease of the ocular anterior segment: basic science and clinical disease, 297

Sorted by citations

Neuropathic pain
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R. L., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,271
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · Cited by 1,302
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,036
Systematic review of incidence and complications of herpes zoster: towards a global perspective
Kawai, K., Gebremeskel, B. G., & Acosta, C. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004833 · Cited by 943
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C. F., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 967
A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 879
Herpes Zoster
Cohen, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1302674 · Cited by 737
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
Kucharzik, T. F., Ellul, P., Greuter, T., Rahier, J. F., Verstockt, B., Abreu, C., Albuquerque, A., Allocca, M., Esteve, M., Farraye, F. A., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab052 · Cited by 511
Management of suspected viral encephalitis in adults – Association of British Neurologists and British Infection Association National Guidelines
Solomon, T., Michael, B. D., Smith, P. E., Sanderson, F., Davies, N. W. S., Hart, I. J., Holland, M., Easton, A., Buckley, C. J., Kneen, R., et al. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.11.014 · Cited by 474
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
Schmader, K. E., Levin, M. J., Gnann, J. W., McNeil, S., Vesikari, T., Betts, R. F., Keay, S. K., Stek, J. E., Bundick, N. D., Su, S.-C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir970 · Cited by 430
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study
Bačkonja, M., Wallace, M. S., Blonsky, E. R., Cutler, B. J., Malan, P. T., Rauck, R. L., & Tobias, J. K. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70228-x · Cited by 420
Neurotrophic keratopathy
Dua, H. S., Said, D. G., Messmer, E. S. B. M., Rolando, M., Benitez-del-Castillo, J. M., Hossain, P. N., Shortt, A. J., Geerling, G., Nubile, M., Figueiredo, F. C., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.003 · Cited by 412
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
Johnson, R. W., Bouhassira, D., Kassianos, G. C., Leplège, A., Schmader, K. E., & Weinke, T. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-37 · Cited by 406
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
Styczyński, J., Reusser, P., Einsele, H., de la Cámara, R., Cordonnier, C., Ward, K. N., Ljungman, P. T., Engelhard, D., & Leukemia, F. T. E. C. O. I. I. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.386 · Cited by 378
Diagnosis and management of neurotrophic keratitis
Lambìase, A., & Sacchetti, M. (2014) · Clinical ophthalmology · doi:10.2147/opth.s45921 · Cited by 373
Clinical Features of Varicella-Zoster Virus Infection
Kennedy, P. G. E., & Gershon, A. A. (2018) · Viruses · doi:10.3390/v10110609 · Cited by 368
Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis
Kawai, K., & Yawn, B. P. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.10.009 · Cited by 312
Clinical Practice Guideline for Physical Therapy Assessment and Treatment in Patients With Nonspecific Neck Pain
Bier, J. D., Scholten-Peeters, G. G. M., Staal, J. B., Pool, J. J. M., van Tulder, M. W., Beekman, E., Knoop, J., Meerhoff, G. A., & Verhagen, A. P. (2017) · Physical Therapy · doi:10.1093/ptj/pzx118 · Cited by 258
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
Dagnew, A. F., İlhan, O., Lee, W. S., Woszczyk, D., Kwak, J., Bowcock, S. J., Sohn, S. K., Macias, G. R., Chiou, T.-J., Quiel, D., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30163-x · Cited by 256
Penetration Enhancers in Ocular Drug Delivery
Moiseev, R. V., Morrison, P. W. J., Steele, D. F., & Khutoryanskiy, V. V. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11070321 · Cited by 250
Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease
Tseng, H. F. (2011) · JAMA · doi:10.1001/jama.2010.1983 · Cited by 238
Herpes Zoster Recurrences More Frequent Than Previously Reported
Yawn, B. P., Wollan, P. C., Kurland, M. J., Sauver, J. L. S., & Saddier, P. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0618 · Cited by 224
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
MOFENSON, L. M., Brady, M. T., Danner, S. P., Dominguez, K. L., Hazra, R., Handelsman, E. L., Havens, P. L., Nesheim, S. R., Read, J. S., Serchuck, L. K., et al. (2009) · PubMed · Cited by 227
European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment
Werner, R. N., Nikkels, A., Marinović, B., Schäfer, M., Czarnecka-Operacz, M. M., Agius, A. M., Bata‐Csörgõ, Z., Breuer, J., Girolomoni, G., Gross, G., et al. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13957 · Cited by 222
Herpes Zoster in the Older Adult
John, A., & Canaday, D. H. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.07.016 · Cited by 220
Management of suspected viral encephalitis in children – Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group National Guidelines
Kneen, R., Michael, B. D., Menson, E., Mehta, B., Easton, A., Hemingway, C. A., Klapper, P. E., Vincent, A. C., Lim, M. J., Carrol, E. D., et al. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.11.013 · Cited by 223
Diagnosis and Assessment of Pain Associated With Herpes Zoster and Postherpetic Neuralgia
Dworkin, R. H., Gnann, J. W., Oaklander, A. L., Raja, S. N., Schmader, K. E., & Whitley, R. J. (2008) · Journal of Pain · doi:10.1016/j.jpain.2007.10.008 · Cited by 212
Risk of Stroke Following Herpes Zoster: A Self-Controlled Case-Series Study
Langan, S. M., Minassian, C., Smeeth, L., & Thomas, S. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu098 · Cited by 163
Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice
Bouhassira, D., Chassany, O., Gaillat, J., Hanslik, T., Launay, O., Mann, C., Rabaud, C., Rogeaux, O., & Strady, C. (2011) · Pain · doi:10.1016/j.pain.2011.10.026 · Cited by 162
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
van Hoek, A. J., Gay, N., Melegaro, A., Opstelten, W., & Edmunds, W. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.024 · Cited by 156
Research design considerations for chronic pain prevention clinical trials
Gewandter, J. S., Dworkin, R. H., Turk, D. C., Farrar, J. T., Fillingim, R. B., Gilron, I., Markman, J. D., Oaklander, A. L., Polydefkis, M. J., Raja, S. N., et al. (2015) · Pain · doi:10.1097/j.pain.0000000000000191 · Cited by 145
Corticosteroids for preventing postherpetic neuralgia
Han, Y., Zhang, J., Chen, N., He, L., Zhou, M., & Zhu, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005582.pub4 · Cited by 136
A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008
Breuer, J., Grose, C. F., Norberg, P., Tipples, G. A., & Schmid, D. S. (2010) · Journal of General Virology · doi:10.1099/vir.0.017814-0 · Cited by 129
Herpes zoster and postherpetic neuralgia
Johnson, R. W. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.30 · Cited by 129
Predictors of Postherpetic Neuralgia Among Patients With Herpes Zoster: A Prospective Study
Drolet, M., Brisson, M., Schmader, K. E., Levin, M. J., Johnson, R. W., Oxman, M. N., Patrick, D. M., Camden, S., & Mansi, J. A. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.02.020 · Cited by 128
Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Pergam, S. A., Limaye, A. P., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13622 · Cited by 128
Herpes zoster and postherpetic neuralgia: prevention and management.
Fashner, J., & Bell, A. L. (2011) · PubMed · Cited by 125
Postherpetic neuralgia: epidemiology, pathophysiology and management
Johnson, R. W., Wasner, G. L., Saddier, P., & Baron, R. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1581 · Cited by 123
Herpes zoster – typical and atypical presentations
Dayan, R. R., & Peleg, R. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1335574 · Cited by 122
Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older
Stein, A., Britt, H. C., Harrison, C. M., Conway, E. L., Cunningham, A. L., & MacIntyre, C. R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.012 · Cited by 121
Barriers to the Use of Herpes Zoster Vaccine
Hurley, L. P., Lindley, M. C., Harpaz, R., Stokley, S. K., Daley, M. F., Crane, L. A., Dong, F., Beaty, B. L., Tan, L., Babbel, C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-9-201005040-00005 · Cited by 120
Herpes Zoster and Postherpetic Neuralgia
Johnson, R. W., Wasner, G. L., Saddier, P., & Baron, R. (2008) · Drugs & Aging · doi:10.2165/0002512-200825120-00002 · Cited by 120
Management of Herpes Zoster and Post-Herpetic Neuralgia
Gan, E. Y., Tian, E. A. L., & Tey, H. L. (2013) · American Journal of Clinical Dermatology · doi:10.1007/s40257-013-0011-2 · Cited by 119
The Impact of the Varicella Vaccination Program on Herpes Zoster Epidemiology in the United States: A Review
Reynolds, M. A., Chaves, S. S., Harpaz, R., Lopez, A. S., & Seward, J. F. (2008) · The Journal of Infectious Diseases · doi:10.1086/522162 · Cited by 117
Herpes zoster
Wareham, D. W., & Breuer, J. (2007) · BMJ · doi:10.1136/bmj.39206.571042.ae · Cited by 115
Increasing Incidence of Herpes Zoster among Veterans
Rimland, D., & Moanna, A. (2010) · Clinical Infectious Diseases · doi:10.1086/651078 · Cited by 113
The Epidemiology of Herpes Zoster in Patients with Newly Diagnosed Cancer
Habel, L. A., Ray, G. T., Silverberg, M. J., Horberg, M. A., Yawn, B. P., Castillo, A., Quesenberry, C. P., Li, Y., Saddier, P., & Tran, T. N. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0815 · Cited by 112
Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
Siberry, G. K., Abzug, M. J., Nachman, S., Brady, M. T., Dominguez, K. L., Handelsman, E. L., MOFENSON, L. M., & Nesheim, S. R. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000437856.09540.11 · Cited by 113
Skin Infections
Clebak, K. T., & Malone, M. A. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2018.05.004 · Cited by 118
Natural History and Treatment of Herpes Zoster
Schmader, K. E., & Dworkin, R. H. (2008) · Journal of Pain · doi:10.1016/j.jpain.2007.10.002 · Cited by 106
Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults
Uscategui, T., Doree, C. J., Chamberlain, I. J., & Burton, M. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006851.pub2 · Cited by 102
The Effectiveness of Repetitive Paravertebral Injections with Local Anesthetics and Steroids for the Prevention of Postherpetic Neuralgia in Patients with Acute Herpes Zoster
Ji, G., Niu, J., Shi, Y., Hou, L., Lü, Y., & Xiong, L. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181b79075 · Cited by 102
Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients
de Broucker, T., Mailles, A., Chabrier, S., Morand, P., & Stahl, J. ‐. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03705.x · Cited by 102
Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve
Gilbert, P. B., Gabriel, E. E., Miao, X., Li, X., Su, S.-C., Parrino, J., & Chan, I. S. F. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu279 · Cited by 102
Neurotrophic keratitis: Frequency, etiologies, clinical management and outcomes
Saad, S., Abdelmassih, Y., Saad, R., Guindolet, D., el-Khoury, S., Doan, S., Cochereau, I., & Gabison, E. E. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.11.008 · Cited by 100
Herpes ZosterAntivirals and Pain Management
Pavan‐Langston, D. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.012 · Cited by 99
Management of herpes zoster and postherpetic neuralgia
Tyring, S. K. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.016 · Cited by 99
Impact of Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy on Health Care Costs
Dworkin, R. H., Malone, D. C., Panarites, C. J., Armstrong, E. P., & Pham, S. V. (2009) · Journal of Pain · doi:10.1016/j.jpain.2009.08.005 · Cited by 97
Herpes zoster infection
Le, P., & Rothberg, M. B. (2019) · BMJ · doi:10.1136/bmj.k5095 · Cited by 96
Neurotrophic keratopathy: current challenges and future prospects
Napier, E., Camacho, M., McDevitt, T. F., & Sweeney, A. R. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2045035 · Cited by 95
New therapies for human cytomegalovirus infections
Britt, W. J., & Prichard, M. N. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.09.003 · Cited by 92
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster
Dworkin, R. H., Barbano, R. L., Tyring, S. K., Betts, R. F., McDermott, M., Pennella‐Vaughan, J., Bennett, G. J., Berber, E., Gnann, J. W., Irvine, C., et al. (2009) · Pain · doi:10.1016/j.pain.2008.12.022 · Cited by 92
Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease‐Modifying Antirheumatic Drugs
Pappas, D. A., Hooper, M. M., Kremer, J. M., Reed, G. W., Shan, Y., Wenkert, D., Greenberg, J. D., & Curtis, J. R. (2015) · Arthritis Care & Research · doi:10.1002/acr.22628 · Cited by 90
Infection in the Elderly
Htwe, T. H., Mushtaq, A., Robinson, S. B., Rosher, R. B., & Khardori, N. M. (2007) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.07.006 · Cited by 88
Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster
Shiraki, K., Yasumoto, S., Toyama, N., & Fukuda, H. (2021) · Viruses · doi:10.3390/v13081547 · Cited by 87
Infection in Renal Transplant Recipients
Fishman, J. A. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.03.006 · Cited by 85
Segmental Zoster Abdominal Paresis (Zoster Pseudohernia): A Review of the Literature
Chernev, I., & Dado, D. N. (2013) · PM&R · doi:10.1016/j.pmrj.2013.05.013 · Cited by 85
A Prospective Study of the Herpes Zoster Severity of Illness
Drolet, M., Brisson, M., Levin, M. J., Schmader, K. E., Oxman, M. N., Johnson, R. W., Camden, S., & Mansi, J. A. (2010) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181eef686 · Cited by 82
Herpes Zoster Presentation, Management, and Prevention: A Modern Case-Based Review
Rosamilia, L. L. (2019) · American Journal of Clinical Dermatology · doi:10.1007/s40257-019-00483-1 · Cited by 80
Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis
Wang, Q., Yang, L., Li, L., Liu, C., Jin, H., & Lin, L. K. (2023) · JMIR Public Health and Surveillance · doi:10.2196/43893 · Cited by 84
Incidence and Clinical Characteristics of Herpes Zoster After Lung Transplantation
Manuel, O., Kumar, D., Singer, L. G., Cobos, I., & Humar, A. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.09.028 · Cited by 79
Clinical and psychosocial correlates of post‐herpetic neuralgia
Volpi, A., Gatti, A., Pica, F., Bellino, S., Marsella, L., & Sabato, A. F. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21254 · Cited by 79
Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: the ectopic pacemaker hypothesis
Devor, M. G. (2018) · PAIN Reports · doi:10.1097/pr9.0000000000000702 · Cited by 78
Herpes Zoster
Schmader, K. E. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.02.011 · Cited by 78
Characterization of the Host Immune Response in Human Ganglia after Herpes Zoster
Gowrishankar, K., Steain, M. C., Cunningham, A. L., Rodriguez, M. J., Blumbergs, P. C., Slobedman, B., & Abendroth, A. (2010) · Journal of Virology · doi:10.1128/jvi.01020-10 · Cited by 78
Recurrence Rate of Herpes Zoster and Its Risk Factors: a Population-based Cohort Study
Kim, Y. J., Lee, C. N., Lee, M. S., Lee, J. H., Lee, J. Y., Han, K., & Park, Y. M. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e1 · Cited by 76
Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy
the VZV Pain Study Group, Parruti, G., Tontodonati, M., Rebuzzi, C., Polilli, E., Sozio, F., Consorte, A., Agostinone, A., Masi, F. D., Congedo, G., et al. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-58 · Cited by 75
Amenamevir, a novel helicase–primase inhibitor, for treatment of herpes zoster: A randomized, double‐blind, valaciclovir‐controlled phase 3 study
Kawashima, M., Nemoto, O., Honda, M., Watanabe, D., NAKAYAMA, J., Imafuku, S., Kato, T., Katsuramaki, T., & the study investigators (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13948 · Cited by 75
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia
Friesen, K. J., Chateau, D., Falk, J., Alessi‐Severini, S., & Bugden, S. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2185-3 · Cited by 74
Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States
Curran, D., Patterson, B. J., Varghese, L., Oorschot, D. V., Buck, P. O., Carrico, J., Hicks, K. A., Lee, B., & Yawn, B. P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.005 · Cited by 74
Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review
Díez‐Domingo, J., Parikh, R., Bhavsar, A. B., Cisneros, E., McCormick, N., & Lecrenier, N. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00549-1 · Cited by 73
Post-herpetic neuralgia – a review of current management and future directions
Schutzer-Weissmann, J. M., & Farquhar-Smith, P. W. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1392508 · Cited by 73
Varicella and herpes zoster vaccine development: lessons learned
Warren‐Gash, C., Forbes, H. J., & Breuer, J. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1394843 · Cited by 71
Evaluation and Treatment of Musculoskeletal Chest Pain
Ayloo, A., Cvengros, T., & Marella, S. (2013) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2013.08.007 · Cited by 71
Herpes Zoster and Recurrent Herpes Zoster
Shiraki, K., Toyama, N., Daikoku, T., Yajima, M., & for the Miyazaki Dermatologist Society (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx007 · Cited by 71
Healthcare Costs of Acute and Chronic Pain Associated with a Diagnosis of Herpes Zoster
Dworkin, R. H., White, R. G., O'connor, A., Başer, O., & Hawkins, K. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01231.x · Cited by 69
Herpes Zoster and Postherpetic Neuralgia in Older Adults
Schmader, K. E. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.03.003 · Cited by 69
Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study
Serpell, M. G., Gater, A., Carroll, S., Abetz‐Webb, L., Mannan, A., & Johnson, R. W. (2014) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-12-92 · Cited by 68
Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies
Lim, D. Z. J., Tey, H. L., Salada, B. M. A., Oon, J. E. L., Seah, E.-J. D., Chandran, N. S., & Pan, J. Y. (2024) · Pathogens · doi:10.3390/pathogens13070596 · Cited by 67
Herpes Zoster
O’Connor, K., & Paauw, D. S. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.02.002 · Cited by 67
Robust Skin Disease Classification by Distilling Deep Neural Network Ensemble for the Mobile Diagnosis of Herpes Zoster
Back, S., Lee, S., Shin, S., Yu, Y., Yuk, T., Jong, S., Ryu, S., & Lee, K. (2021) · IEEE Access · doi:10.1109/access.2021.3054403 · Cited by 69
A 70-Year-Old Woman With Shingles
Whitley, R. J. (2009) · JAMA · doi:10.1001/jama.2009.822 · Cited by 66
Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study
Gater, A., Abetz‐Webb, L., Carroll, S., Mannan, A., Serpell, M. G., & Johnson, R. W. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-402 · Cited by 62
Herpes Zoster Ophthalmicus
Sanjay, S., Huang, P. K., & Lavanya, R. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0098-1 · Cited by 61
Antivirals for Management of Herpes Zoster Including Ophthalmicus: A Systematic Review of High-Quality Randomized Controlled Trials
McDonald, E. M., de Kock, J., & Ram, F. S. (2011) · Antiviral Therapy · doi:10.3851/imp2011 · Cited by 59
Herpes Zoster and Postherpetic Neuralgia: Past, Present and Future
Bennett, G. J., & Watson, C. P. N. (2009) · Pain Research and Management · doi:10.1155/2009/380384 · Cited by 57
Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults
Uscategui, T., Doree, C. J., Chamberlain, I. J., & Burton, M. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006852.pub2 · Cited by 57
Orofacial Pain: A Guide for the Headache Physician
Shephard, M. K., MacGregor, E. A., & Zakrzewska, J. M. (2013) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12272 · Cited by 56
Ulcerative, Vesicular, and Bullous Lesions
Woo, S. B., Setterfield, J. F., & Greenberg, M. S. (2021) · doi:10.1002/9781119597797.ch3 · Cited by 56
Antiviral Agents
Paintsil, E., & Cheng, Y.-C. (2009) · Encyclopedia of Microbiology · doi:10.1016/b978-012373944-5.00178-4 · Cited by 55

Authors: Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., Nurmikko, T. J., Oaklander, A. L., Oxman, M. N., Langston, D. P., Petersen, K. L., Rowbotham, M. C., Schmader, K. E., Stacey, B. R., Tyring, S. K., Wijck, A. J. M. V., Wallace, M. S., Wassilew, S. W., & Whitley, R. J.
Affiliations: University of Rochester Medicine (US)
University of Bristol (GB)
Queen Mary University of London (GB)
Birmingham VA Medical Center (US)
University of Colorado Denver (US)
Columbia University (US)
Helsinki University Hospital (FI)
Royal Hallamshire Hospital (GB)
University of Liverpool (GB)
Harvard University (US)
University of California San Diego (US)
University of California, San Francisco (US)
Duke University (US)
The University of Texas Health Science Center at Houston (US)
Utrecht University (NL)
Helios Klinikum Krefeld (DE)
University of Alabama at Birmingham (US)
Corresponding author: Dworkin, Robert H.
ORCID: Dworkin, Robert H.
Johnson, Robert W.
Breuer, Judith
Levin, Myron J.
Gershon, Anne A.
Haanpää, Maija L.
Nurmikko, Turo J.
Oaklander, Anne Louise
Petersen, Karin L.
Schmader, Kenneth E.
Tyring, Stephen K.
Wijck, Albert J. M. van
Wallace, Mark S.
Whitley, Richard J.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2007-01-01
Volume: 44
Issue: Supplement_1
Pages: S1-S26
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1086/510206
OpenAlex: W2104761404
Cited by: 869
References: 253
Citations by year: 2026: 34 · 2025: 39 · 2024: 48 · 2023: 51 · 2022: 51 · 2021: 46 · 2020: 46 · 2019: 37 · 2018: 48 · 2017: 52 · 2016: 43 · 2015: 46 · 2014: 50 · 2013: 52 · 2012: 43
FWCI: 24.59
Type: journal article
Language: en
Open access: closed
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: herpes zoster, antiviral therapy, acyclovir, brivudin, famciclovir, valacyclovir, first-line therapy, postherpetic neuralgia, treatment guidelines, treatment costs, quality of life
MeSH terms: Valacyclovir, Famciclovir, Acyclovir, Analgesics, Anti-Inflammatory Agents, Antiviral Agents, Bromodeoxyuridine, Herpes Zoster, Humans, Immunocompetence, Valine, Herpesvirus 3, Human, 2-Aminopurine, Immunocompromised Host

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recommendations for the Management of Herpes Zoster

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks